| NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 68094-077-62 | 68094-077 | HUMAN PRESCRIPTION DRUG | Lithium | Lithium Citrate | SOLUTION | ORAL | 20251024 | N/A | ANDA | ANDA218036 | Precision Dose, Inc. | LITHIUM CITRATE | 8 meq/5mL | 3 TRAY in 1 CASE (68094-077-62) / 10 CUP, UNIT-DOSE in 1 TRAY / 5 mL in 1 CUP, UNIT-DOSE (68094-077-59) |
| 72888-172-46 | 72888-172 | HUMAN PRESCRIPTION DRUG | Lithium | Lithium | SOLUTION | ORAL | 20221109 | N/A | ANDA | ANDA218036 | Advagen Pharma Ltd | LITHIUM CITRATE | 8 meq/5mL | 500 mL in 1 BOTTLE (72888-172-46) |
| 70518-4227-0 | 70518-4227 | HUMAN PRESCRIPTION DRUG | Lithium | Lithium | SOLUTION | ORAL | 20241104 | N/A | ANDA | ANDA218036 | REMEDYREPACK INC. | LITHIUM CITRATE | 8 meq/5mL | 10 CUP in 1 BOX (70518-4227-0) / 5 mL in 1 CUP (70518-4227-1) |
| 70518-4227-2 | 70518-4227 | HUMAN PRESCRIPTION DRUG | Lithium | Lithium | SOLUTION | ORAL | 20241105 | N/A | ANDA | ANDA218036 | REMEDYREPACK INC. | LITHIUM CITRATE | 8 meq/5mL | 10 CUP, UNIT-DOSE in 1 BOX (70518-4227-2) / 10 mL in 1 CUP, UNIT-DOSE (70518-4227-3) |